Andecaliximab - CAS 1518996-49-0

Andecaliximab is a recombinant IgG4 monoclonal antibody targeting matrix metalloproteinase 9 (MMP9) . Andecaliximab showed antifibrotic effects in a mouse model of idiopathic pulmonary fibrosis. Andecaliximab can be used to study gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF), as well as dengue virus.

MMP, Virus Protease

Microbiology/Virology, Proteases/Proteasome

1518947

>95%

-20°C

Ice Packs

Inhibitory Antibodies